HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,330,000 | -7.4% | 48,011 | -1.0% | 1.77% | -19.2% |
| Q4 2020 | $5,759,000 | +34.7% | 48,499 | -1.0% | 2.19% | +7.1% |
| Q3 2020 | $4,276,000 | +17.7% | 49,004 | +20.8% | 2.04% | +22.6% |
| Q2 2020 | $3,632,000 | -21.8% | 40,559 | -12.9% | 1.67% | -25.9% |
| Q1 2020 | $4,643,000 | -0.3% | 46,590 | +14.9% | 2.25% | +17.3% |
| Q4 2019 | $4,658,000 | -8.9% | 40,541 | 0.0% | 1.92% | -13.0% |
| Q3 2019 | $5,114,000 | +33.8% | 40,541 | +27.6% | 2.20% | +4.7% |
| Q2 2019 | $3,823,000 | +38.3% | 31,765 | +0.5% | 2.10% | +30.8% |
| Q1 2019 | $2,765,000 | -13.4% | 31,609 | -0.9% | 1.61% | -22.6% |
| Q4 2018 | $3,192,000 | -2.1% | 31,902 | +12.1% | 2.08% | +2.7% |
| Q3 2018 | $3,260,000 | +22.6% | 28,450 | -4.1% | 2.02% | +20.5% |
| Q2 2018 | $2,660,000 | +18.6% | 29,657 | -3.2% | 1.68% | +11.4% |
| Q1 2018 | $2,242,000 | +33.5% | 30,644 | +6.0% | 1.51% | +23.8% |
| Q4 2017 | $1,679,000 | +29.5% | 28,900 | 0.0% | 1.22% | +25.7% |
| Q3 2017 | $1,297,000 | +23.5% | 28,900 | +8.7% | 0.97% | +10.5% |
| Q2 2017 | $1,050,000 | – | 26,587 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |